Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1987 1
1989 2
1992 2
1993 1
1994 1
1996 4
1997 2
1998 2
1999 3
2000 7
2001 6
2002 5
2003 6
2004 6
2005 5
2006 7
2007 7
2008 18
2009 7
2010 12
2011 8
2012 20
2013 15
2014 20
2015 18
2016 22
2017 28
2018 27
2019 22
2020 39
2021 52
2022 67
2023 53
2024 16

Text availability

Article attribute

Article type

Publication date

Search Results

465 results

Results by year

Filters applied: . Clear all
The following terms were ignored: %, %, %, %, %
The following terms were not found in PubMed: 22Helicobacter, 2Fimmunology, 5BMeSH
Page 1
[Asthenic post-COVID syndrome].
Khaibullina DK, Maksimov YN. Khaibullina DK, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2023;123(3):61-69. doi: 10.17116/jnevro202312303161. Zh Nevrol Psikhiatr Im S S Korsakova. 2023. PMID: 36946399 Russian.
Before the start of the study, in addition to a physical examination, the patient's condition was assessed using the following questionnaires and scales: VAS for asthenia, subjective scale for assessing asthenia (MFI-20), L.D. Malkova, a questionnaire for the quality of life (EQ- …
Before the start of the study, in addition to a physical examination, the patient's condition was assessed using the following questionnaire …
Exploratory clinical efficacy and patient-reported outcomes from NOVA: A randomized controlled study of intravenous natalizumab 6-week dosing versus continued 4-week dosing for relapsing-remitting multiple sclerosis.
Ryerson LZ, Foley JF, Defer G, Cohen JA, Arnold DL, Butzkueven H, Cutter G, Giovannoni G, Killestein J, Wiendl H, Sinks S, Kuhelj R, Bodhinathan K, Lasky T. Ryerson LZ, et al. Mult Scler Relat Disord. 2023 Apr;72:104561. doi: 10.1016/j.msard.2023.104561. Epub 2023 Feb 11. Mult Scler Relat Disord. 2023. PMID: 36931078 Free article. Clinical Trial.
At week 72, there were no significant differences between Q6W and Q4W groups in LSM change from baseline for T25FW (0.00, P = 0.975), 9HPT (dominant [0.22, P = 0.533] or nondominant [0.09, P = 0.862] hand), or SDMT (-1.03, P = 0.194). Similarly, there were no significant d …
At week 72, there were no significant differences between Q6W and Q4W groups in LSM change from baseline for T25FW (0.00, P = 0.975), 9HPT ( …
Subjective symptoms as predictors for eosinophilic chronic rhinosinusitis with nasal polyps in the Chinese population.
Zhang C, Wang H, Zhang Q, Chen J, Yu H, Li W, Xu H, Hu L, Wang D, Sun X. Zhang C, et al. Eur Arch Otorhinolaryngol. 2023 Aug;280(8):3721-3729. doi: 10.1007/s00405-023-07905-1. Epub 2023 Mar 14. Eur Arch Otorhinolaryngol. 2023. PMID: 36917251
METHODS: A total of 102 patients with CRSwNP who underwent endoscopic sinus surgery were prospectively enrolled. The Sinonasal Outcomes Test-22 scores (SNOT-22), EuroQol 5-dimensional Questionnaire scores (ED-5D), and Lund-Mackay scores by computed tomography …
METHODS: A total of 102 patients with CRSwNP who underwent endoscopic sinus surgery were prospectively enrolled. The Sinonasal Outcomes Test …
Health utility reporting in chronic rhinosinusitis patients.
Bewick J, Morris S, Hopkins C, Erskine S, Philpott CM. Bewick J, et al. Clin Otolaryngol. 2018 Feb;43(1):90-95. doi: 10.1111/coa.12903. Epub 2017 Jun 13. Clin Otolaryngol. 2018. PMID: 28498517
We plotted EQ-5D-5L VAS and utility scores and SF-12 MCS and PCS scores separately against SNOT-22 scores and quantified associations using bivariate ordinary least squares regression analysis. ...Mean index score computed form the EQ-5D-5L was 0.75. Worse (h …
We plotted EQ-5D-5L VAS and utility scores and SF-12 MCS and PCS scores separately against SNOT-22 scores and quantified assoc …
Stability of SARS-CoV-2 on inanimate surfaces: A review.
Xu J, Xu C, Chen R, Yin Y, Wang Z, Li K, Shi J, Chen X, Huang J, Hong J, Yuan R, Liu Y, Liu R, Wang Y, Liu X, Zhang Z. Xu J, et al. Microbiol Res. 2023 Jul;272:127388. doi: 10.1016/j.micres.2023.127388. Epub 2023 Apr 20. Microbiol Res. 2023. PMID: 37141851 Free PMC article. Review.
The results showed that the half-life of SARS-CoV-2 on different contact materials was generally 2-10 h, up to 5 d, and as short as 30 min at 22 C, whereas the half-life of SARS-CoV-2 on non-porous surfaces was generally 5-9 h d, up to 3 d, and as short as 4 min at 22 …
The results showed that the half-life of SARS-CoV-2 on different contact materials was generally 2-10 h, up to 5 d, and as short as 30 min a …
Anterior cervical discectomy and fusion versus posterior decompression in patients with degenerative cervical myelopathy: a systematic review and meta-analysis.
Sattari SA, Ghanavatian M, Feghali J, Rincon-Torroella J, Yang W, Xu R, Bydon A, Witham T, Belzberg A, Theodore N, Lubelski D. Sattari SA, et al. J Neurosurg Spine. 2023 Feb 24:1-13. doi: 10.3171/2023.1.SPINE221244. Online ahead of print. J Neurosurg Spine. 2023. PMID: 36840737
METHODS: MEDLINE and PubMed were searched from inception to February 22, 2022. The primary outcomes were Neck Disability Index (NDI), SF-36 Physical Component Summary (PCS), modified Japanese Orthopaedic Association (mJOA) scale, visual analog scale (VAS), and EQ-5D …
METHODS: MEDLINE and PubMed were searched from inception to February 22, 2022. The primary outcomes were Neck Disability Index (NDI), …
EN-DALBACEN 2.0 Cohort: real-life study of dalbavancin as sequential/consolidation therapy in patients with infective endocarditis due to Gram-positive cocci.
Hidalgo-Tenorio C, Sadyrbaeva-Dolgova S, Enríquez-Gómez A, Muñoz P, Plata-Ciezar A, Miró JM, Alarcón A, Martínez-Marcos FJ, Loeches B, Escrihuela-Vidal F, Vinuesa D, Herrero C, Boix-Palop L, Del Mar Arenas M, Vázquez EG, de Las Revillas FA, Pasquau J; EN-DALBACEN study group. Hidalgo-Tenorio C, et al. Int J Antimicrob Agents. 2023 Sep;62(3):106918. doi: 10.1016/j.ijantimicag.2023.106918. Epub 2023 Jul 11. Int J Antimicrob Agents. 2023. PMID: 37442488 Free article.
OBJECTIVES: Infective endocarditis (IE) has high mortality and morbidity and requires long hospital stays to deliver the antibiotic treatment recommended in clinical practice guidelines. ...Coagulase-negative staphylococci (38.8%), Staphylococcus aureus (22.6%), Ent …
OBJECTIVES: Infective endocarditis (IE) has high mortality and morbidity and requires long hospital stays to deliver the antibiotic t …
The socioeconomic cost of chronic rhinosinusitis study.
Wahid NW, Smith R, Clark A, Salam M, Philpott CM. Wahid NW, et al. Rhinology. 2020 Apr 1;58(2):112-125. doi: 10.4193/Rhin19.424. Rhinology. 2020. PMID: 32172284
Data on demographic and socioeconomic characteristics, out-of-pocket expenditure (OOPE), health resource utilisation, productivity losses and health-related quality of life (HRQoL) via the EQ-5D and SNOT-22 instruments, were collected from questionnaires. ...
Data on demographic and socioeconomic characteristics, out-of-pocket expenditure (OOPE), health resource utilisation, productivity losses an …
Nivolumab plus ipilimumab versus chemotherapy as first-line treatment in advanced non-small-cell lung cancer with high tumour mutational burden: patient-reported outcomes results from the randomised, open-label, phase III CheckMate 227 trial.
Reck M, Schenker M, Lee KH, Provencio M, Nishio M, Lesniewski-Kmak K, Sangha R, Ahmed S, Raimbourg J, Feeney K, Corre R, Franke FA, Richardet E, Penrod JR, Yuan Y, Nathan FE, Bhagavatheeswaran P, DeRosa M, Taylor F, Lawrance R, Brahmer J. Reck M, et al. Eur J Cancer. 2019 Jul;116:137-147. doi: 10.1016/j.ejca.2019.05.008. Epub 2019 Jun 11. Eur J Cancer. 2019. PMID: 31195357 Free article. Clinical Trial.
During treatment, mean changes from baseline with nivolumab + ipilimumab showed early, clinically meaningful improvements in LCSS ASBI/3-IGI and EQ-5D VAS/UI; with chemotherapy, symptoms and health-related quality of life remained stable (LCSS ASBI/3-IGI, EQ-5D UI) …
During treatment, mean changes from baseline with nivolumab + ipilimumab showed early, clinically meaningful improvements in LCSS ASBI/3-IGI …
Establishing utility values for the 22-item Sino-Nasal Outcome Test (SNOT-22) using a crosswalk to the EuroQol-five-dimensional questionnaire-three-level version (EQ-5D-3L).
Crump RT, Lai E, Liu G, Janjua A, Sutherland JM. Crump RT, et al. Int Forum Allergy Rhinol. 2017 May;7(5):480-487. doi: 10.1002/alr.21917. Epub 2017 Feb 9. Int Forum Allergy Rhinol. 2017. PMID: 28182331
METHODS: This study used data collected from patients diagnosed with CRS awaiting bilateral endoscopic sinus surgery in Vancouver, Canada. Study participants completed both the SNOT-22 and the EQ-5D-3L. Ordinary least squares was used for 3 models that estimated the …
METHODS: This study used data collected from patients diagnosed with CRS awaiting bilateral endoscopic sinus surgery in Vancouver, Canada. S …
465 results